# Huatai Pharma Inc. – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/huatai-pharma-inc/67e7868b-4433-4b6d-9562-80e3e1c9ccd5
Source feed: FDA_Inspections

> FDA inspection 1202319 of Huatai Pharma Inc., March 24, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202319
- Company Name: Huatai Pharma Inc.
- Inspection Date: 2023-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.keypedia.com/companies/huatai-pharma-inc/71180d7f-d680-423c-b1b3-bada1228d5ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c